ZOOPRO

This brand name is authorized in Nigeria.

Active ingredients

The drug ZOOPRO contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 5E8K9I0O4U - CIPROFLOXACIN
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6546	Tablet	Zoopro-500 Tablets TAB 500 mg 1 x 10's (in AIu-AIu blister)	Film Coated Tablet White colored, oblong shaped, biconvex film-coated tablets, plain on one side and a break line on the other side 47 RNW-PP-231853 ZOOPRO-500 TABLETS ciprofloxacin 500mg ciprofloxacin 500mg B4-6546 Drugs Imported Products 1x10 Prescription Only Medicine (POM) 2/14/2022 ZOOMOTA HEALTH CARE LIMITED, PLOT 3, FAGBEYIRO LAYOUT IDC ROAD ORITA CHALLENGE IBADAN 7050812884 zoomotahealthcareltd@gmail.com M/s. ASSOCIATED BIOTECH, Village Kishanpura,Guru Majra Nalagarh Road,Baddi,Dist.Solan.Teh.:Nalagarh,Himachal Pradesh(INDIA), India	27/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6546